A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial.
CANCER RESEARCH AND TREATMENT（2024）
关键词
Squamous cell carcinoma of head and neck,Precision medicine,Umbrella trial,NGS,Nintedanib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要